Interestingly, truncation mutations of RHNO1 that eliminate the region of the protein in which this putative phosphorylation site occurs, and which are therefore unlikely to be unable to bind TOPBP1, have been identified in a number of families with hereditary pancreatic cancer (Smith et al., 2016). This evidence concerns the gene TOPBP1 and pancreatic neoplasm.